Physician profile
Gary L Berg
NPI 1083698997
$546.43
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.78 · 2021: $24.92 · 2022: $181 · 2023: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.10 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $196.06 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $82.75 | 2022-2023 | Dupixent |
| Sanofi-Aventis U.S. LLC | $78.99 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $71.96 | 2022-2023 | Tezspire, Breztri, Airsupra |
| Genzyme Corporation | $33.93 | 2023 | |
| Axsome Therapeutics, INC. | $24.02 | 2023 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $20.63 | 2023 | Glassia |
| Pulmonx Corporation | $20.29 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Boston Scientific Corporation | $17.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.